z-logo
open-access-imgOpen Access
Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
Author(s) -
Sarrazin Christoph,
Boesecke Christoph,
GolsabahiBroclawski Solmaz,
Moog Gero,
Negro Francesco,
Silaidos Carmina,
Patel Polly,
Lohmann Kristina,
Spinner Christoph D.,
Walcher Stephan,
Wedemeyer Heiner,
Wörns MarcusAlexander
Publication year - 2021
Publication title -
health science reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 7
ISSN - 2398-8835
DOI - 10.1002/hsr2.290
Subject(s) - hepatitis c virus , medicine , hepatitis c , environmental health , intensive care medicine , virology , virus
Abstract Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has set a goal to eliminate HCV by 2030. Despite the availability of direct‐acting antivirals—highly effective and well‐tolerated therapies for HCV—many patients infected with HCV in Germany have not initiated treatment, including a majority of those who are aware of their positive diagnosis. Barriers to screening, diagnosis, and treatment are major factors taking many countries off track for HCV elimination by 2030. Identifying country‐specific barriers and challenges, particularly in at‐risk populations such as people who inject drugs or men who have sex with men, has the potential to create tailored programs and strategies to increase access to screening or treatment and engage at‐risk populations. This review aims to report the current steps toward HCV elimination in Germany, the country‐specific barriers and challenges that will potentially prevent reaching the 2030 HCV elimination goal and describe good practice examples to overcome these barriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here